Skip to main content
Premium Trial:

Request an Annual Quote

ABI/MDS Sciex, Pfizer, and Sound Analytics to Develop New ADME Software

This update clarifies the title of Laura Lauman, who is president of ABI's proteomics and small molecule division.
 
NEW YORK (GenomeWeb News) — Applied Biosystems, MDS Sciex, Pfizer, and Sound Analytics plan to develop software that will work with high-throughput automation technology to improve compound analysis.
 
The technology will focus on improving techniques for analyzing absorption, distribution, metabolism, and excretion. 
 
By improving the “timeliness and accuracy” of information drawn from ADME testing, ABI said, the new software would increase the efficiency of the pre-clinical drug-development process. 
 
Pfizer R&D Director Cornelis Hop said that because a swift analysis of the characteristics of compounds is a “major challenge in drug discovery,” drug makers “need a new approach that delivers rapid turnaround of ADME-related assay data.”
 
Laura Lauman, president of ABI's proteomics and small molecule division, said that the end goal of the project is to help drug makers kill bad compounds early and often.

Filed under

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.